Protecting women from cervical cancer
Cervical cancer is a preventable disease, yet it kills about 275,000 women each year, mostly in low-income countries. PATH is working on screening methods that are rapid, affordable, and easy to use—even in rural areas without sophisticated laboratory facilities. We’re also helping countries plan strategic use of vaccines against human papillomavirus, the leading cause of cervical cancer, as part of a comprehensive approach to protecting women from the disease.
Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention—Utility and Program Planning
The PATH project, Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention—Utility and Program Planning (START-UP), is introducing low-cost, easy-to-use, and culturally acceptable screening and treatment strategies for cervical cancer in low-resource countries. The project aims to make rapid, accurate precancer screening feasible and accessible at lower levels of the public health care system, and to increase the number and types of staff able to provide effective and efficient screening and treatment services.
This five-minute video presentation by START-UP project director, Dr. Jose Jeronimo, features two new molecular tests for cervical precancer and cancer screening:
Run time: 4:57. Copyright 2012, PATH.
Cervical Cancer Vaccine project
From 2006 to 2011, PATH conducted demonstration projects in four low- to middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) vaccines.
The work was implemented in three phases:
- Formative research to explore the knowledge, attitudes, and beliefs of diverse audiences, and to better understand health system and policy factors.
- Demonstration vaccination programs, informed by the formative research data, to evaluate strategies for reaching girls with HPV vaccine.
- Rapid dissemination of lessons learned and technical assistance to governments and nongovernmental organizations that wish to develop or scale up HPV vaccination programs, including assistance with completing applications to GAVI for subsidized HPV vaccine.
The RHO Cervical Cancer website offers users a vast, searchable library of cervical cancer information.
RHO makes it easy to access background papers, training materials, films, PowerPoint presentations, and a host of other documents and tools published by the world’s leading HPV experts and organizations, including the World Health Organization, US Centers for Disease Control and Prevention, US National Cancer Institute, International Union Against Cancer, PATH, and many others.
RHO also features PATH’s interactive Cervical Cancer Prevention Action Planner, a tool for decision-making related to screening and treatment programs for adult women and vaccination programs for girls.